Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Voltron Therapeutics, Inc. See All Filings	D/A	2023-11-09 15:20:10 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers Laidlaw & Company (UK) Ltd. CIK Number 0001835742 Filed Document 0001493152-23-040030 Exclusions or Exemptions 506b Accepted Date 2023-11-09 15:20:10 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Voltron Therapeutics, Inc. See All Filings	D	2022-11-09 14:32:51 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers Laidlaw & Company (UK) Ltd. CIK Number 0001835742 Filed Document 0001493152-22-031074 Exclusions or Exemptions 506b Accepted Date 2022-11-09 14:32:51 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Voltron Therapeutics, Inc. See All Filings	D	2022-06-16 17:18:30 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers Laidlaw & Company (UK) Ltd. CIK Number 0001835742 Filed Document 0001493152-22-016994 Exclusions or Exemptions 506b Accepted Date 2022-06-16 17:18:30 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Voltron Therapeutics, Inc. See All Filings	D	2021-09-01 12:33:23 UTC
Amount To Be Raised $12,000,000 Associated Brokers / Dealers Laidlaw & Company (UK) Ltd. CIK Number 0001835742 Filed Document 0001493152-21-021753 Exclusions or Exemptions 506b Accepted Date 2021-09-01 12:33:23 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Voltron Therapeutics, Inc. See All Filings	D	2021-07-13 14:55:42 UTC
Amount To Be Raised $3,349,428 Associated Brokers / Dealers Laidlaw & Company (UK) Ltd. CIK Number 0001835742 Filed Document 0001493152-21-016710 Exclusions or Exemptions 506b Accepted Date 2021-07-13 14:55:42 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Debt